Case Reports

61-year-old woman • nausea • paresthesia • cold allodynia • Dx?

Author and Disclosure Information

 

References

Treatment of ciguatera may include intravenous (IV) mannitol infusion. Other treatments, such as amitriptyline, gabapentin, pregabalin, and tocainide, have been used, but there is limited supporting evidence and they appear variably effective.7

Mannitol reverses the effects of ciguatoxin, with suppression of spontaneous action potentials and reversal of neuronal edema.8,9 It is reasonable to offer mannitol for acute or persistent symptoms of ciguatera fish poisoning even after a delay of several weeks.

Ciguatoxin confers no characteristic taste or smell to the fish. Thus, people who prepare or eat contaminated seafood have no reliable means to detect and avoid it.

A recent systematic review found that mannitol has the largest body of evidence supporting its use, although that evidence is generally of low quality (case reports and large case series).7 While these reports10-13 describe beneficial effects of mannitol, a single randomized trial suggested that mannitol is no more effective than normal saline.14 However, this study was underpowered and had inadequate treatment concealment; twice as many saline control patients as mannitol-treated patients requested a rescue dose of mannitol.14

Mannitol may be most effective when given early in the course of ciguatera but has shown some success when given later.5,12,13 In 1 large case series, the longest interval from symptom onset to successful treatment was 70 days, although most patients with satisfactory results received mannitol in the first few days.5

Our patient was administered an IV infusion of 100 g of 20% mannitol over 1 hour. She received the infusion 140 days after the onset of her symptoms and experienced rapid symptom relief.

Continue to: At a follow-up visit...

Recommended Reading

Robust immune response after COVID-19 boosters in those with IBD
MDedge Family Medicine
Dupilumab shows histological and clinical benefit in larger eosinophilic esophagitis cohort
MDedge Family Medicine
Managing overuse of food IgE panels: Multiple approaches needed
MDedge Family Medicine
Vaccine update: The latest recommendations from ACIP
MDedge Family Medicine
COVID-19 often more severe with congenital heart defects
MDedge Family Medicine
New contact lens elutes antihistamine for ocular allergy
MDedge Family Medicine
Pollution levels linked to physical and mental health problems
MDedge Family Medicine
Anaphylaxis risk with IV iron low, but varies with formulation
MDedge Family Medicine
Children and teens with food allergies face quality-of-life issues
MDedge Family Medicine
Denosumab boosts bone strength in glucocorticoid users
MDedge Family Medicine